| scholarly article | Q13442814 |
| P50 | author | Georg A. Roth | Q38640006 |
| Bernhard Moser | Q42428017 | ||
| P2093 | author name string | C Back | |
| A Zuckermann | |||
| H J Ankersmit | |||
| E Wolner | |||
| S Roedler | |||
| G Boltz-Nitulescu | |||
| K Lietz | |||
| S Gerlitz | |||
| I Teufel | |||
| P2860 | cites work | Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. | Q52970184 |
| Cardiac allograft vasculopathy: a review. | Q55067225 | ||
| Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass | Q73198469 | ||
| Regulatory role of Th-2 cytokines, IL-10 and IL-4, in cardiac allograft rejection | Q73983771 | ||
| Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans | Q77299281 | ||
| CD95(APO-1/Fas)-mediated apoptosis: live and let die | Q77903149 | ||
| Caspases in T-cell receptor-induced thymocyte apoptosis | Q77921184 | ||
| Allograft vasculopathy: diagnosing the nemesis of heart transplantation | Q78077678 | ||
| Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome | Q78124745 | ||
| Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device | Q78201101 | ||
| A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain | Q24306835 | ||
| The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 | ||
| Interleukin-10 | Q28263225 | ||
| FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex | Q28283294 | ||
| Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis | Q28344926 | ||
| Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages | Q29616355 | ||
| Induction of rapid histone degradation by the cytotoxic T lymphocyte protease Granzyme A. | Q31520093 | ||
| Cardiac transplant vasculopathy | Q34104081 | ||
| The apoptosis-1/Fas protein in human systemic lupus erythematosus | Q34131476 | ||
| Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 | ||
| Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
| Differential ability of T cell subsets to undergo activation-induced cell death | Q36158748 | ||
| High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. | Q36362685 | ||
| Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl | Q36365371 | ||
| CD14 is a component of multiple recognition systems used by macrophages to phagocytose apoptotic lymphocytes | Q40946052 | ||
| FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis | Q41224805 | ||
| IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis | Q41340330 | ||
| Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients | Q41737060 | ||
| Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
| Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus | Q46580276 | ||
| Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus | Q47915599 | ||
| Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. | Q51083614 | ||
| Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. | Q51098492 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 183-189 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy | |
| P478 | volume | 127 |
| Q98186539 | "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" |
| Q44546820 | Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. |
| Q39022829 | Natural killer cells in inflammatory heart disease. |
| Q44555497 | Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. |
Search more.